Construction and in vivo/in vitro evaluation of a nanoporous ion-responsive targeted drug delivery system for recombinant human interferon α-2b delivery

Construction and in vivo/in vitro evaluation of a nanoporous ion-responsive targeted drug delivery system for recombinant human interferon α-2b delivery

Hongfei Liu,1 Jie Zhu,1 Pengyue Bao,2 Yueping Ding,3 Yan Shen,4 Thomas J Webster,5 Ying Xu11College of Pharmacy, Jiangsu University, Zhenjiang 212013, People’s Republic of China; 2Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Nanjing 210023, People’s Republic of China; 3Jiangs...

Full description

Bibliographic Details
Main Authors:	Liu H, Zhu J, Bao P, Ding Y, Shen Y, Webster TJ, Xu Y
Format:	Article
Language:	English
Published:	Dove Medical Press 2019-07-01
Series:	International Journal of Nanomedicine
Subjects:	nano-porous ion-responsive recombinant human interferon α-2b (rhIFNα-2b) ion exchange technique sustained release lung targeting
Online Access:	https://www.dovepress.com/construction-and-in-vivoin-vitro-evaluation-of-a-nanoporous-ion-respon-peer-reviewed-article-IJN

Similar Items

DEVELOPMENT AND CHARACTERIZATION OF POLYCLONAL ANTIBODY OF RECOMBINANT HUMAN INTERFERON Α2B IN NEW ZEALAND WHITE RABBIT
by: Heny Rachmawati, et al.
Published: (2014-07-01)

Recombinant Human IFNα-2b Response Promotes Vaginal Epithelial Cells Defense against Candida albicans
by: Zhaohui Liu, et al.
Published: (2017-04-01)

Certification of a pharmacopoeial reference standard for potency testing of recombinant interferon α-2b
by: L. A. Gaiderova, et al.
Published: (2024-03-01)

B. C. G. plus recombinant interferon α2b in superficial bladder cancer
by: Gyan Prakash Singh, et al.
Published: (2001-01-01)

Use of Recombinant α-2b-Interferon in the Treatment of Acute Respiratory Viral Diseases in Children
by: O.Ye. Chernyshova
Published: (2016-09-01)

Interferon-alpha-2b induces autophagy in hepatocellular carcinoma cells through Beclin1 pathway
by: Jun Zhao, et al.
Published: (2014-03-01)

IFN-λ1 in CHO cells: its expression and biological activity
by: Wu-mei Yuan, et al.
Published: (2017-12-01)

Magnetic Relaxation Switching Assay Using IFNα-2b-Conjugated Superparamagnetic Nanoparticles for Anti-Interferon Antibody Detection
by: Boris Nikolaev, et al.
Published: (2023-06-01)

Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysis
by: Mykhailo Buchynskyi, et al.
Published: (2023-01-01)

Topical Interferon Alpha 2b in the Treatment of Refractory Diabetic Macular Edema
by: Arash Maleki, et al.
Published: (2020-10-01)

Forms and Methods for Interferon’s Encapsulation
by: Thelvia I. Ramos, et al.
Published: (2021-09-01)

Development of novel-nanobody-based lateral-flow immunochromatographic strip test for rapid detection of recombinant human interferon α2b
by: Xi Qin, et al.
Published: (2022-04-01)

Microtiter miniature shaken bioreactor system as a scale-down model for process development of production of therapeutic alpha-interferon2b by recombinant Escherichia coli
by: Joo Shun Tan, et al.
Published: (2018-01-01)

LOCAL APPLICATION OF RECOMBINANT INTERFERON-ALFA2 FOR TREATMENT OF RECURRENT RESPIRATORY PAPILLOMATOSIS
by: M. Plouzhnikov, et al.
Published: (2014-07-01)

Depression and anxiety disorders during pegylated interferon treatment in patients with chronic hepatitis B
by: Ozen Onen Sertoz, et al.
Published: (2017-01-01)

Interferon and interferon-stimulated genes in HBV treatment
by: Qirong Li, et al.
Published: (2022-12-01)

Pharmacokinetic studies of the recombinant bovine interferon-alpha in cattle
by: Hai-Yang YU, et al.
Published: (2018-10-01)

<i>In vitro</i> activity of human recombinant alpha-2b interferon against SARS-CoV-2 virus
by: S. Ya. Loginova, et al.
Published: (2021-05-01)

Intratumoral recombinant human interferon alpha‐2a and vincristine combination therapy in canine transmissible venereal tumour
by: Halit Kanca, et al.
Published: (2018-11-01)

Efficacy and safety of interferon α-2b spray for herpangina in children: A randomized, controlled trial
by: Ying-Zi Ye, et al.
Published: (2021-06-01)

Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study
by: Shashi Bhushan B L, et al.
Published: (2021-10-01)

Development of a cultivation process for the enhancement of human interferon alpha 2b production in the oleaginous yeast, <it>Yarrowia lipolytica</it>
by: Gasmi Najla, et al.
Published: (2011-11-01)

Aspects of a Methodological Approach to Determination of Interferon Alpha Specific Activity
by: M. L. Baykova, et al.
Published: (2020-03-01)

Interferon Alpha Induces Cellular Autophagy and Modulates Hepatitis B Virus Replication
by: Jia Li, et al.
Published: (2022-02-01)

“Interferon magic” in ocular surface squamous neoplasia
by: Sinumol Sukumaran Thulaseedharan, et al.
Published: (2018-01-01)

Unilateral retinopathy post perilesional interferon α2b injections for ocular surface squamous cell carcinoma
by: Shiv Dalla, et al.
Published: (2021-12-01)

Experimental study of the acute toxicity of the oral form of pegylated interferon α2-b
by: D. N. Kinsht, et al.
Published: (2019-02-01)

Theoretical study on pegylation reaction mechanisms of IFN-α-2a, IFN-α-2b and IFN-β-1a
by: Taqavian Mohammad, et al.
Published: (2017-01-01)

Antiviral activity of recombinant porcine interferon-α against porcine transmissible gastroenteritis virus in pk-15 cells
by: ZHAO J, et al.
Published: (2017-07-01)

The effect of recombinant human interferon α1b treatment of infants hospitalized with lower respiratory tract infection on subsequent wheezing
by: Lihua Yang, et al.
Published: (2021-11-01)

Measurement of serum interferon alpha in Egyptian patients with systemic lupus erythematosus and evaluation of its effect on disease activity: a case-control study
by: A. Fayed, et al.
Published: (2020-11-01)

Direct and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow
by: Fei Xiong, et al.
Published: (2022-09-01)

Enterovirus A71 2B Inhibits Interferon-Activated JAK/STAT Signaling by Inducing Caspase-3-Dependent Karyopherin-α1 Degradation
by: Menghuai Sun, et al.
Published: (2021-12-01)

Acute and sub-chronic toxicity study of recombinant bovine interferon alpha in rodents
by: Yu Hai-Yang, et al.
Published: (2021-05-01)

Hormone therapy affecting interferon defense in children with infectious mononucleosis
by: I. M. Fedorova, et al.
Published: (2021-11-01)

Type 1–type 2 interferon imbalance in dry eye disease
by: Trailokyanath Panigrahi, et al.
Published: (2023-01-01)

Conjunctival squamous papilloma refractory to interferon α-2b in a patient on systemic immunosuppression (tacrolimus)
by: Preethi S. Ganapathy, et al.
Published: (2017-06-01)

An Emerging Role for Type I Interferons as Critical Regulators of Blood Coagulation
by: Tristram A. J. Ryan, et al.
Published: (2023-02-01)

Efficacy of pegylated interferon α-2b plus entecavir therapy and predictors of treatment success in children with chronic hepatitis B
by: Liang Huang, et al.
Published: (2023-12-01)

Efficacy of Dorsal Root Ganglion Pulsed Radiofrequency Combined with Paravertebral Injection of Recombinant Human Interferon-α2b in Herpetic Neuralgia
by: Fei Y, et al.
Published: (2021-03-01)